Barely Significant
← all excerpts

Marginal zone lymphoma: present status and future perspectives.

Haematologica · 2022 · PMC8719063 · PMID 34985232

1
hedged sentence
closest p
boldest claim

The sentences

94 Overall, the study indicated an improvement in PFS (hazard ratio=0.46) from the addition of lenalidomide although this did not reach statistical significance in the small subset of patients with MZL.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.